October 3, 2011 -- Guizhou Bailing Group Pharmaceutical will acquire Zhengxin Pharmaceutical for 28 million RMB ($4.4 million). Zhengxin owns two patents for Miao ethnic medicines, which is Bailing’s specialty. The Zhengxin acquisition is the third company with Miao products that Bailing has bought this year. Bailing is building a larger portfolio of Miao ethnic TCMs to gain a market leading position in the sector. More details....
Stock Symbol: (SHE: 002424)
